Dr. Nassiri is selected to the International Society for Study of Vascular Anomalies (ISSVA) task force on classification of vascular anomalies
Dr. Nassiri is selected to represent the United States and the Specialty of Vascular Surgery on the International Society for Study of Vascular Anomalies (ISSVA) Ad-hoc Committee for Classification of Vascular Anomalies.Source: ISSVA Newsletter Vol 5 - No 1 | April 2021
Yale Cancer Center’s Dr. Lieping Chen Elected to Prestigious National Academy of Sciences
As one of the highest honors in the scientific field, Lieping Chen, MD, PhD, United Technologies Corporation Professor in Cancer Research, Professor of Immunobiology, Dermatology, and of Medical Oncology, and Co-Director of the Cancer Immunology Program at Yale Cancer Center, was elected to the National Academy of Sciences (NAS).
Survival after Mohs Surgery for Invasive Melanoma Associated with Treatment Facility
Early-stage invasive melanoma excised with Mohs micrographic surgery at academic and top decile-volume facilities was associated with improved long-term survival, according to a study published in JAMA Dermatology.Source: Healio Dermatology
YSM Students Advance COVID-19 Vaccination Efforts with Innovative Community-academic Partnerships and Advocacy
Yale School of Medicine students, in collaboration with a diverse set of other students and community members, are playing a significant role in the vaccination campaign in New Haven, in Connecticut, and nationally.
Dr. Valentina Greco serves as Genetics’ Inaugural Vice Chair of Diversity; Establishes Diversity Advisory Committee
Valerie Reinke, Vice Chair of the Department and Professor of Genetics, announced the creation of a Vice Chair of Diversity position. The new role was designed to “establish a framework to scrutinize [the Department’s] current practices and truly commit to change that enhances diversity.” Dr. Reinke acknowledged the need for more intention in “advocating for and facilitating the presence and advancement of under-represented groups.”
Yale Study Shows Combined Liver–Cytokine Humanization Rescues Circulating Red Blood Cells for Testing of Novel Therapeutics
In a new study by the Yale Department of Immunobiology and Yale Cancer Center, researchers report combined liver and growth factor humanization enhances human red blood cell production and survival in circulation the immunodeficient murine host.
MD-PhD Student Eric Song Receives Prestigious Harold M. Weintraub Graduate Student Award
Eric Song, a fifth-year Yale School of Medicine (YSM) MD-PhD student, is one of the recipients of the 2021 Harold M. Weintraub Graduate Student Award, which recognizes outstanding achievement during graduate studies in the biological sciences. The awardees are selected based on the quality, originality, and scientific significance of their research, as well as to represent a diverse range of research topics.
The Yale Vascular Malformations Program (VaMP) identifies a culprit gene mutation implicated in the pathogenesis of "hepatic hemangiomas".
The Yale New Haven Hospital Vascular Malformations Program (VaMP), via a collaborative multidisciplinary effort, has identified somatic mosaic gene mutations (GJA4 encoding connexin 37) implicated in the pathogenesis of so-called “HEPATIC HEMANGIOMAS” in adult patients. This discovery questions the validity of the very term “hemangioma” in this particular anatomic distribution; and renders – for the first time - objective scientific support to the radiographically and clinically suspected notion that these lesions actually represent VENOUS MALFORMATIOMS - an entity with a completely different natural history, hemodynamics, angioarchitectural profile, and ergo therapeutic susceptibility.Source: Cutaneous and hepatic vascular lesions due to a recurrent somatic GJA4 mutation reveal a pathway for vascular malformation